순환종양세포 시장 규모, 점유율, 성장 분석 : 기술별, 용도별, 제품별, 검체별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)
Circulating Tumor Cell Market Size, Share, and Growth Analysis, By Technology, By Application, By Product, By Specimen, By End Use, By Region - Industry Forecast 2025-2032
상품코드:1687596
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 순환종양세포 시장 규모는 2023년에 122억 달러로 평가되며, 2024년 135억 5,000만 달러에서 2032년에는 314억 6,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 11.1%로 성장할 전망입니다.
세계 순환종양세포(CTC) 시장은 암 진단의 기술 혁신과 암 발병률 증가로 인해 역동적으로 성장하고 있습니다. 비침습적 진단 툴, 특히 CTC 분석에 대한 수요는 맞춤형 의료로의 전환과 암의 조기 발견에 대한 절박한 필요성에 의해 촉진되고 있습니다. 그러나 기술적 복잡성과 표준화 부족으로 인해 비침습적 진단 툴의 광범위한 보급을 가로막고 있습니다. 현재 ELISA법과 PCR법이 제품의 주류를 차지하고 있습니다. 북미가 큰 시장 점유율을 차지하고 있는 것은 탄탄한 의료 인프라에 기인합니다. 이 시장은 진화하는 의료 환경에 대응하고 환자 결과를 개선하기 위한 지속적인 연구 구상, 공동 연구 및 혁신적인 제품 개발로 특징지어집니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
순환종양세포 시장 규모 : 기술별 & CAGR(2025-2032)
시장 개요
CTC 탐지 및 농축 방법
면역 포착(라벨 기반)
포지티브 셀렉션
네거티브 셀렉션
사이즈 기반 분리(라벨 프리)
막 기반
마이크로플루이딕스 기반
밀도 기반 분리(라벨 프리)
조합 방법
CTC 직접 검출법
SERS
현미경검사
기타
CTC 분석
순환종양세포 시장 규모 : 용도별 & CAGR(2025-2032)
시장 개요
임상/액체생검
리스크 평가
스크리닝과 모니터링
조사
암 줄기세포와 종양 형성 조사
의약품·치료법 개발
순환종양세포 시장 규모 : 제품별 & CAGR(2025-2032)
시장 개요
키트와 시약
채혈관
디바이스 또는 시스템
순환종양세포 시장 규모 : 검체별 & CAGR(2025-2032)
시장 개요
혈액
골수
기타 체액
순환종양세포 시장 규모 : 최종 용도별 & CAGR(2025-2032)
시장 개요
조사·학술기관
병원과 진료소
진단 센터
순환종양세포 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Sysmex Corporation(Japan)
Bio-Techne Corporation(USA)
Thermo Fisher Scientific Inc.(USA)
Miltenyi Biotec GmbH(Germany)
Biolidics Limited(Singapore)
ScreenCell(France)
Greiner Bio-One International GmbH(Austria)
AVIVA Biosciences(USA)
BIOCEPT, Inc.(USA)
Ikonisys, Inc.(USA)
Epic Sciences(USA)
Rarecells Diagnostics(France)
STEMCELL Technologies, Inc.(Canada)
Precision for Medicine(USA)
ANGLE plc(UK)
Creatv MicroTech, Inc.(USA)
결론과 제안
KSA
영문 목차
영문목차
Global Circulating Tumor Cell Market size was valued at USD 12.2 billion in 2023 and is poised to grow from USD 13.55 billion in 2024 to USD 31.46 billion by 2032, growing at a CAGR of 11.1% during the forecast period (2025-2032).
The global Circulating Tumor Cell (CTC) market is witnessing dynamic growth, driven by innovations in cancer diagnostics and an increasing incidence of cancer. The demand for non-invasive diagnostic tools, particularly CTC analysis, is fueled by a shift towards personalized medicine and a pressing need for early cancer detection. However, challenges such as technological complexities and the lack of standardization hinder broader adoption. Currently, ELISA and PCR-based methods dominate the product landscape. North America commands a significant market share attributed to its robust healthcare infrastructure. The market is characterized by continuous research initiatives, collaborative efforts, and innovative product developments aimed at addressing the evolving medical landscape and enhancing patient outcomes.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Circulating Tumor Cell market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Circulating Tumor Cell Market Segments Analysis
Global Circulating Tumor Cell Market is segmented by Technology, Application, Product, Specimen, End Use and region. Based on Technology, the market is segmented into CTC detection & enrichment methods, CTC Direct Detection Methods and CTC Analysis. Based on Application, the market is segmented into Clinical/ Liquid Biopsy and Research. Based on Product, the market is segmented into Kits & Reagents, Blood Collection Tubes and Devices or Systems. Based on specimen, the market is segmented into Blood, Bone Marrow and Other Body Fluids. Based on End Use, the market is segmented into Research and academic institutes, Hospital and clinics and Diagnostic centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Circulating Tumor Cell Market
The rising incidence of cancer worldwide has intensified the demand for advanced diagnostic tools, with circulating tumor cell (CTC) analysis gaining prominence as a non-invasive and valuable technique for cancer detection and monitoring. Additionally, the focus on personalized medicine and the urgency for early cancer diagnosis are driving the adoption of CTC technologies. This growing need for effective diagnostic solutions is reshaping the global landscape of cancer management and treatment, fostering innovation and advancements in the CTC market, which aims to provide better outcomes for patients through improved detection and monitoring capabilities.
Restraints in the Global Circulating Tumor Cell Market
One of the primary challenges facing the global circulating tumor cell (CTC) market is the technological complexity involved in CTC analysis. This intricacy complicates the process and highlights the need for standardization across various methodologies, which hinders widespread acceptance and implementation. Furthermore, concerns regarding the reliability and reproducibility of CTC results create additional barriers, making it difficult for these techniques to be integrated into standard clinical practices. As such, these factors collectively contribute to limiting the overall growth and adoption of CTC technologies in the healthcare sector, restraining market potential.
Market Trends of the Global Circulating Tumor Cell Market
The global circulating tumor cell (CTC) market is witnessing a significant trend characterized by the increasing integration of CTC analysis into routine clinical practice. This shift is driven by the technology's ability to facilitate real-time cancer progression tracking and treatment response evaluation. Advances in innovative technologies such as microfluidic systems and sophisticated molecular detection techniques are enhancing the precision and sensitivity of CTC analysis. Additionally, the rising awareness and adoption of liquid biopsy methods for cancer diagnostics underscore the critical role of CTCs as valuable biomarkers. This convergence of technology and clinical application is poised to revolutionize cancer care and diagnosis.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Circulating Tumor Cell Market Size by Technology & CAGR (2025-2032)
Market Overview
CTC detection & enrichment methods
Immunocapture (label-based)
Positive selection
Negative selection
Size-based separation (label-free)
Membrane-based
Microfluidic-based
Density-based separation (label-free)
Combined methods
CTC Direct Detection Methods
SERS
Microscopy
Others
CTC Analysis
Global Circulating Tumor Cell Market Size by Application & CAGR (2025-2032)
Market Overview
Clinical/ Liquid Biopsy
Risk Assessment
Screening and Monitoring
Research
Cancer stem cell & tumorogenesis research
Drug/therapy development
Global Circulating Tumor Cell Market Size by Product & CAGR (2025-2032)
Market Overview
Kits & Reagents
Blood Collection Tubes
Devices or Systems
Global Circulating Tumor Cell Market Size by Specimen & CAGR (2025-2032)
Market Overview
Blood
Bone Marrow
Other Body Fluids
Global Circulating Tumor Cell Market Size by End Use & CAGR (2025-2032)
Market Overview
Research and academic institutes
Hospital and clinics
Diagnostic centers
Global Circulating Tumor Cell Market Size & CAGR (2025-2032)
North America (Technology, Application, Product, Specimen, End Use)
US
Canada
Europe (Technology, Application, Product, Specimen, End Use)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Technology, Application, Product, Specimen, End Use)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Technology, Application, Product, Specimen, End Use)
Brazil
Rest of Latin America
Middle East & Africa (Technology, Application, Product, Specimen, End Use)
